Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-TIGIT, OMP-313M32 Vector   (CAT#: GTVCR-WQ2134MR)

This product GTVCR-WQ2134MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting TIGIT. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Humanized
RefSeq NM_173799.4
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 201633
UniProt ID Q495A1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-TIGIT, OMP-313M32 Vector (GTVCR-WQ2134MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1203MR IVTScrip™ pT7-VEE-mRNA-Anti-CD19, FMC63 scFv-28Z CAR Vector Vector FMC63 scFv-28Z CAR
GTVCR-WQ657MR IVTScrip™ pSP6-VEE-mRNA-Anti-PDCD1, BCD-100 Vector Vector BCD-100
GTVCR-WQ2604MR IVTScrip™ pSP6-VEE-mRNA-Anti-AXL, UNII-FFX71LCS5T Vector Vector UNII-FFX71LCS5T
GTVCR-WQ584MR IVTScrip™ pT7-VEE-mRNA-Anti-S, AZD8895 Vector Vector AZD8895
GTVCR-WQ2187MR IVTScrip™ pT7-VEE-mRNA-Anti-MADCAM1, PF-00547659 Vector Vector PF-00547659
GTVCR-WQ1346MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD52, GZ-402668 Vector Vector GZ-402668
GTVCR-WQ201MR IVTScrip™ pSP6-VEE-mRNA-Anti-VEGFA, ABP 215 Vector Vector ABP 215
GTVCR-WQ2239MR IVTScrip™ pT7-VEE-mRNA-Anti-PRLR, PR-1594804 Vector Vector PR-1594804
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.